Skip to main content
. 2016 Jan 4;2016(1):CD006995. doi: 10.1002/14651858.CD006995.pub2

4.4. Analysis.

4.4

Comparison 4 Subgroup analyses ‐ by diagnostic group: mifepristone vs placebo as adjunct to combination treatment, Outcome 4 Global state: 1. General ‐ no clinically significant improvement ‐ people with psychotic depression (< 30% improvement BPRS).